| dc.contributor.author | Wong, A. | |
| dc.contributor.author | Hirpara, J. | |
| dc.contributor.author | Pervaiz, Shazib | |
| dc.contributor.author | Eu, J. | |
| dc.contributor.author | Sethi, G. | |
| dc.contributor.author | Goh, B. | |
| dc.date.accessioned | 2017-08-24T02:22:16Z | |
| dc.date.available | 2017-08-24T02:22:16Z | |
| dc.date.created | 2017-08-23T07:21:44Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | Wong, A. and Hirpara, J. and Pervaiz, S. and Eu, J. and Sethi, G. and Goh, B. 2017. Do STAT3 inhibitors have potential in the future for cancer therapy?. Expert Opinion on Investigational Drugs. 26 (8): pp. 883-887. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/56081 | |
| dc.identifier.doi | 10.1080/13543784.2017.1351941 | |
| dc.title | Do STAT3 inhibitors have potential in the future for cancer therapy? | |
| dc.type | Journal Article | |
| dcterms.source.volume | 26 | |
| dcterms.source.number | 8 | |
| dcterms.source.startPage | 883 | |
| dcterms.source.endPage | 887 | |
| dcterms.source.issn | 1354-3784 | |
| dcterms.source.title | Expert Opinion on Investigational Drugs | |
| curtin.department | School of Biomedical Sciences | |
| curtin.accessStatus | Open access via publisher | |
